Wearable Fitness Technology Could Foretell The Future Of Remote Patient Monitoring

Wearable wireless monitoring devices geared toward the fitness market are beginning to attract the attention of the health care industry, which recognizes the technology’s potential to provide an ideal patient monitoring tool. As more of this technology makes its way into the clinical setting, this trend is poised to change the traditional view of what is and is not a medical device.

As a technology, digital health has achieved a great deal in the past 10 years, with significant advances in computerization, wireless communication, and customized algorithms. However, the application of digital health technology is still a work in progress as the industry tries to determine the best ways to utilize the innovation coming from the cyber world in a demanding health care system. One of the areas where this technology seems to be a natural fit is remote patient monitoring, and the rise of interest in fitness-oriented devices (as well as health and wellness products) is starting to cross over into the clinical space. Investors, device manufacturers, and even some clinicians say the wireless technology currently being used in fitness products, and particularly the concept of wearable medical devices, has the potential to help a much larger population in the health care field and could improve the outlook for patients with a variety of conditions. As a result, this market is garnering a good deal of attention from companies and investors looking for “the next big thing” in health care technology.

Although the market for wearable medical devices is still in its infancy, projections have already started pouring in on the...

More from United States

Philips Announces Major Investment In US Manufacturing And Expansion Of Pennsylvania Facility

 

Philips says the expansion of its facility in Reedsville, PA, will not only boost its capacity to produce AI-enabled ultrasounds that are used in hospitals across the US but will also create 120 well-paying jobs.

Breathing Easy: Freespira Works To Expand Access To Panic And PTSD Treatment

 
• By 

Freespira’s device has been FDA-approved to treat panic disorders and PTSD. CEO Joe Perekupka told Medtech Insight the company’s innovative approach includes patient coaching, insurance partnerships to identify potential users, and lobbying for broader insurance coverage for digital therapeutics.

Warning Letters - July 2025

The US FDA posted three warning letters in July, covering medical supply kits, wearables and orthopedics.

Inaccurate Carbon Dioxide Readings Prompt Class I Recall Of Draeger Ventilation Filters

 

Draeger Medical has recalled certain SafeStar and TwinStar ventilation filters after reports of serious injuries caused by misleading carbon dioxide readings.

More from North America

FDA Panel Supports Dermal Fillers For Décolletage Use

 
• By 

An FDA panel has endorsed the use of dermal fillers for décolletage, but warned of patient safety concerns. The filler can cause complications with future imaging and pregnancy or breastfeeding, panelists said. Regulatory measures and patient studies are recommended for better outcomes.

Apreo Health Raises $130M, First Patient Treated In US Clinical Trial

 

Apreo Health CEO Karun Naga talks to Medtech Insight about the company’s intentions for its Series B funding. The Breathe-3 clinical trial and early commercialization activities, involving physician education, are top priorities.

NAD Alerts Agendia Over Endorsing Physician’s Ties To Firm

 
• By 

The National Advertising Division (NAD) alerted Agendia to improve disclosure regarding a physician endorsing its MammaPrint test. The physician's ties to Agendia were inadequately revealed in LinkedIn posts.